Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PMAs Are The New Reality For Metal-On-Metal Hips

This article was originally published in The Gray Sheet

Executive Summary

A final order from FDA calls for manufacturers to submit PMAs or take their metal-on-metal hip devices off the market by May 18. The widely anticipated move is part of a broader response to elevated adverse event rates tied to the products.


Related Content

J&J Wins Mesh Case, But Slammed With $247m Penalty On Hips
J&J Ordered To Pay $502 Million In Hip Suit
Planning Board Proposes Postmarket Device Surveillance Timeline
FDA Proposes PMAs For Metal-On-Metal Hips
Researchers Push FDA To Raise Standards For Metal-On-Metal Hips
Metal-On-Metal Hips Get Failing Grade In New Registry Analysis
FDA Orders Post-Market Studies On Metal-On-Metal Hips
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts